These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 520688)

  • 1. Changes of risk and benefit in immunization against pertussis and tuberculosis.
    Ambrosch F; Wiedermann G
    Dev Biol Stand; 1979; 43():85-90. PubMed ID: 520688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the benefit of immunization].
    Ambrosch VF; Wiedermann G; Kundi M
    Fortschr Med; 1977 Jan; 95(3):159-62. PubMed ID: 838425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modern trends in vaccination policy: evaluation of benefits, risks and cost (author's transl)].
    Wiedermann G
    Wien Klin Wochenschr; 1979 Mar; 91(5):143-50. PubMed ID: 106558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the pertussis vaccination programme in England and Wales and its effects on whooping cough morbidity and mortality.
    Griffith AH
    Dev Biol Stand; 1979; 43():91-4. PubMed ID: 520689
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trendobservation of beneficial effects of vaccinations (author's transl)].
    Ambrosch F; Wiedermann G; Kundi M
    Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):541-7. PubMed ID: 610249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of preventive vaccination on the epidemiologic situation of pertussis in Poland].
    Adonajlo A
    Przegl Epidemiol; 1968; 22(2):189-201. PubMed ID: 5669181
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems of active whooping cough preventive vaccination in Austria].
    Hayek HW
    Wien Med Wochenschr; 1968 Nov; 118(44):937-41. PubMed ID: 4387879
    [No Abstract]   [Full Text] [Related]  

  • 8. [Eradication of whooping cough by preventive vaccination].
    Bierschenk H
    Dtsch Gesundheitsw; 1971 Oct; 26(40):1897-900. PubMed ID: 5141701
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefits and risks of immunization against pertussis.
    Stuart-Harris C
    Dev Biol Stand; 1979; 43():75-83. PubMed ID: 520687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit analysis of BCG-vaccination in Austria.
    Ambrosch F; Klima H; Wiedermann G
    Dev Biol Stand; 1979; 43():121-6. PubMed ID: 118066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy.
    Rota MC; D'Ancona F; Massari M; Mandolini D; Giammanco A; Carbonari P; Salmaso S; Ciofi degli Atti ML
    Vaccine; 2005 Nov; 23(46-47):5299-305. PubMed ID: 16112254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution to vaccination statistics in childhood].
    Hayek H
    Wien Med Wochenschr; 1968 May; 118(20):462-4. PubMed ID: 5702496
    [No Abstract]   [Full Text] [Related]  

  • 13. Pertussis vaccine--an analysis of benefits, risks and costs.
    Koplan JP; Schoenbaum SC; Weinstein MC; Fraser DW
    N Engl J Med; 1979 Oct; 301(17):906-11. PubMed ID: 39253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pertussis: a reemerging infection?].
    Kriz B; Fabiánová K; Maixnerová M; Benes C; Malý M
    Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):51-65. PubMed ID: 17593802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of protective vaccination on the epidemiologic situation of pertussis in Poland. I. Epidemiologic analysis of pertussis in Warsaw in 1962-1965 and in Lódź in 1963-1965].
    Adonajlo A
    Przegl Epidemiol; 1967; 21(1):33-42. PubMed ID: 6044681
    [No Abstract]   [Full Text] [Related]  

  • 16. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morbidity and mortality of infectious diseases determined mass vaccination in children under 5 ans in Bamako District].
    Diawara A; Sangho H; Sango H; Sacko M; Sow S; Toure K; Doumbo O; Simaga SY;
    Mali Med; 2006; 21(4):8-11. PubMed ID: 19437838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspects of epidemiology and prevention of whooping cough].
    Muzzi A
    Nuovi Ann Ig Microbiol; 1971; 22(5):293-323. PubMed ID: 5169958
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of prophylactic whooping-cough vaccination. An attempt at an evaluation based on experiences in Denmark].
    Lautrop H; Mikkelsen OS
    Ugeskr Laeger; 1969 Apr; 131(17):735-41. PubMed ID: 4307508
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
    Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J
    Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.